27.03.2012
- Illumina, a gene-mapping company facing a $5.7 billion hostile takeover bid by Swiss drugmaker Roche Holding, was sued by Columbia University on Monday for allegedly infringing...
26.03.2012
- Roche extended its $5.7 billion cash bid for U.S. gene decoder Illumina for a second time as the Swiss drugmaker sticks to its tried and tested M&A strategy of playing a long game...
